Stratasys Ltd. at its Annual General Meeting to be held on June 21, 2013, to approve an amendment to Amended and Restated Articles of Association to increase the number of directors constituting Board of Directors from nine to ten by adding an unclassified director and to make conforming changes to the Articles of Association. The company also consider to approve an amendment to Articles of Association to increase the number of authorized ordinary shares from 60 million ordinary shares to 180 million ordinary shares and correspondingly increase the share capital of company from ILS 600,000 to ILS 1,800,000.

Stratasys Ltd. announced the immediate availability of VeroDentPlus MED690 dental material for the Objet EdenV series of 3D Printers. VeroDentPlus MED690 enables the 3D printing of dental models that are highly accurate, economical to produce, and offer the appearance of dental stone with fine details and resolution. The new material can be used in conjunction with all open intra-oral impression and plaster scanners and is optimized for printing models for crowns, bridges, orthodontic appliances, and implants. VeroDentPlus MED690 expands Stratasys growing family of materials for digital dentistry. Designed especially for use in dental and orthodontic solutions, these materials combine accurate detail visualization with high dimensional stability.

Stratasys Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported net sales of $97,207,000 against $44,964,000 for the same period last year. Net loss attributable to company was $15,536,000 or $0.40 per basic and diluted share compared to net income attributable to company of $4,522,000 or $0.21 per basic and diluted share for the same period last year. Operating loss was $16,740,000 against operating income of $7,227,000 a year ago. Loss before income taxes was $16,226,000 against income before income taxes of $7,523,000 a year ago. Non-GAAP operating income was $20,302,000 against $16,458,000 a year ago. Non-GAAP income before income taxes was $20,816,000 against $16,651,000 a year ago. Non-GAAP net income attributable to company was $17,580,000 or $0.43 per diluted share compared $12,588,000 or $0.32 per diluted share for the same period last year. The company confirmed earnings guidance for the fiscal year ending December 31, 2013. The company announced revenue guidance of $430 million to $445 million. Non-GAAP earnings guidance is expected to be $1.29 to $1.38 per diluted share. GAAP earnings guidance is expected to be $0.41 to $0.16 per share loss.